Fig. 1 · Structure
Documents & Downloads
BMS-1001 hydrochloride
PD-L1/PD-1 Inhibitor
BMS-1001 hydrochloride is an orally active inhibitor of the PD-L1/PD-1 immune checkpoint pathway. It demonstrates low cytotoxicity across various cell lines, making it suitable for research applications. The compound has an IC50 value of 2.25 nM in homogeneous time-resolved fluorescence (HTRF) binding assays, indicating potent inhibition of PD-1 interactions. BMS-1001 is useful for studies focused on cancer immunotherapy and the modulation of immune responses.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2113650-04-5 |
| Applications | PD-L1/PD-1 Inhibitor |
| Formula | C35H35ClN2O7 |
| Molecular Weight | 631.11 |
| SMILES | OC[C@@H](NCC1=CC(C)=C(C=C1OCC2=CC=CC(C#N)=C2)OCC3=CC=CC(C4=CC=C5OCCOC5=C4)=C3C)C(O)=O.[H]Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.